Perceptive Advisors – 4D MOLECULAR THERAPEUTICS IN

Perceptive Advisors ownership history of 4D MOLECULAR THERAPEUTICS IN
QuarterValueSharesWeighting
Q1 2021$38,596
55.1%
889,756
48.2%
0.24%
-8.6%
Q4 2020$24,881600,2560.27%